Evaluation of Intraocular Pressure After Water Drinking Test in Patients with Unilateral Hemifacial Spasm

Autor: Low JR, Wong CW, Loo JL, Milea D, Perera SA, Lee YF, Ng SR, Baskaran M, Nongpiur ME, Tow SLC

Publikováno v: Clinical Ophthalmology, Vol Volume 14, Pp 1675-1680 (2020)

Jin Rong Low,1– 3 Chee Wai Wong,1,3– 6 Jing Liang Loo,1,3,5– 8 Dan Milea,3,5,7,8 Shamira A Perera,1– 3,5 Yi Fang Lee,3,9 Si Rui Ng,1– 3 Mani Baskaran,2,3,5 Monisha Esther Nongpiur,2,3,5 Sharon Lee Choon Tow1,3,5– 8 1Department of Cataract

Externí odkaz: https://doaj.org/article/55cc5d4b21bb4f6788e906a7d6cae8a3

A Lung Cancer Mouse Model Database.

Autor: Cai L, Gao Y, DeBerardinis RJ, Acquaah-Mensah G, Aidinis V, Beane JE, Biswal S, Chen T, Concepcion-Crisol CP, Grüner BM, Jia D, Jones R, Kurie JM, Lee MG, Lindahl P, Lissanu Y, Lorz Lopez MC, Martinelli R, Mazur PK, Mazzilli SA, Mii S, Moll H, Moorehead R, Morrisey EE, Ng SR, Oser MG, Pandiri AR, Powell CA, Ramadori G, Santos Lafuente M, Snyder E, Sotillo R, Su KY, Taki T, Taparra K, Xia Y, van Veen E, Winslow MM, Xiao G, Rudin CM, Oliver TG, Xie Y, Minna JD

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 May 14. Date of Electronic Publication: 2024 May 14.

PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.

Autor: Yao X; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore. yao.xiaosai@gene.com.; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA. yao.xiaosai@gene.com., Hong JH; Duke-NUS Medical School, Singapore, Republic of Singapore., Nargund AM; Duke-NUS Medical School, Singapore, Republic of Singapore., Ng MSW; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Heng HL; National Cancer Centre Singapore, Singapore, Republic of Singapore., Li Z; National Cancer Centre Singapore, Singapore, Republic of Singapore., Guan P; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Sugiura M; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Republic of Singapore., Chu PL; Duke-NUS Medical School, Singapore, Republic of Singapore., Wang LC; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; SingMass - National Mass Spectrometry Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Functional Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Ye X; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA., Qu J; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Kwek XY; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Republic of Singapore., Lim JCT; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Ooi WF; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Koh J; National Cancer Centre Singapore, Singapore, Republic of Singapore., Wang Z; Duke-NUS Medical School, Singapore, Republic of Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Pan YF; National Cancer Centre Singapore, Singapore, Republic of Singapore.; Department of Medical Genetics, Zunyi Medical University, Zunyi, China., Ong YS; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Tan KY; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; SingMass - National Mass Spectrometry Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Functional Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Goh JY; Duke-NUS Medical School, Singapore, Republic of Singapore.; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Republic of Singapore., Ng SR; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Pignata L; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore., Huang D; National Cancer Centre Singapore, Singapore, Republic of Singapore., Lezhava A; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Tay ST; Duke-NUS Medical School, Singapore, Republic of Singapore., Lee M; Duke-NUS Medical School, Singapore, Republic of Singapore., Yeo XH; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Tam WL; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Republic of Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Republic of Singapore., Rha SY; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea., Li S; Duke-NUS Medical School, Singapore, Republic of Singapore., Guccione E; Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Futreal A; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX, USA., Tan J; Sun Yat-sen University Cancer Center, Guangzhou, China., Yeong JPS; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Hong W; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Yauch R; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA., Chang KT; Duke-NUS Medical School, Singapore, Republic of Singapore.; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Republic of Singapore., Sobota RM; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; SingMass - National Mass Spectrometry Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Functional Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Tan P; Duke-NUS Medical School, Singapore, Republic of Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Republic of Singapore., Teh BT; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; National Cancer Centre Singapore, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.

Publikováno v: Nature cell biology [Nat Cell Biol] 2023 May; Vol. 25 (5), pp. 765-777. Date of Electronic Publication: 2023 Apr 24.

Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice.

Autor: Hamza B; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Miller AB; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Department of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Meier L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany.; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Stockslager M; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Ng SR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., King EM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Lin L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., DeGouveia KL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biomedical Engineering, Wentworth Institute of Technology, Boston, MA, USA., Mulugeta N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Calistri NL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Strouf H; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Bray C; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Rodriguez F; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Freed-Pastor WA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chin CR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Jaramillo GC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Burger ML; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Weinberg RA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Shalek AK; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Department of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA.; Department of Immunology, Massachusetts General Hospital, Boston, MA, USA., Jacks T; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Manalis SR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. srm@mit.edu.; Ludwig Center at MIT's Koch Institute for Integrative Cancer Research, Cambridge, MA, USA. srm@mit.edu.

Publikováno v: Nature communications [Nat Commun] 2021 Sep 28; Vol. 12 (1), pp. 5680. Date of Electronic Publication: 2021 Sep 28.

Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1.

Autor: Romero R; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Sánchez-Rivera FJ; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Westcott PMK; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Mercer KL; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Bhutkar A; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Muir A; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA., González Robles TJ; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Rodríguez SL; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Liao LZ; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Ng SR; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Li L; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Colón CI; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA., Naranjo S; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Beytagh MC; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA., Lewis CA; Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, USA., Hsu PP; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Bronson RT; Tufts University, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Jacks T; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA. tjacks@mit.edu.; Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA. tjacks@mit.edu.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. tjacks@mit.edu.

Publikováno v: Nature cancer [Nat Cancer] 2020 Sep; Vol. 1 (9), pp. 935.